Posts Tagged ‘acute myocardial infarction’

February 16th, 2015

Selections from Richard Lehman’s Literature Review: February 16th

This week’s topics include blood pressure lowering in type 2 diabetes and the trajectories of risk after hospitalization for HF, acute MI, or pneumonia.


January 26th, 2015

Selections from Richard Lehman’s Literature Review: January 26th

This week’s topics include dietary sodium content, mortality, and CVD risk in older adults, the ROX CONTROL HTN study, and more.


December 18th, 2014

Demystifying the Taboo of Sex Counseling After Acute MI

Stacy Lindau discusses her research group’s study of sexual-activity counseling for adults, age 18 to 55, in the U.S. and Spain during the first month after acute MI.


March 10th, 2014

Selections from Richard Lehman’s Literature Review: March 10th

This week’s topics include cognitive function and brain structure in type 2 diabetics after intensive lowering of BP and lipid levels, the association of β-blocker therapy with risks of adverse CV events and deaths in those with ischemic heart disease undergoing noncardiac surgery, and more.


February 25th, 2014

Is Post-MI Statin Therapy Appropriately Intensive?

Suzanne V. Arnold discusses her research group’s study of statin initiation, intensification, and maximization after acute myocardial infarction.


February 3rd, 2014

Selections from Richard Lehman’s Literature Review: February 3rd

This week’s topics include biomarkers for systemic sclerosis, the effectiveness of ICDs for primary prevention of sudden cardiac death, and more.


January 30th, 2014

Selections from Richard Lehman’s Literature Review: January 30th

This week’s topics include articles on the FDA’s premarket approval of cardiac implantable electronic devices, the Stryker Wingspan stent system, and more.


December 17th, 2012

Selections from Richard Lehman’s Literature Review: December 17th

This week’s topics include a study on ICD programming to reduce inappropriate therapy and mortality, a clinical review of diagnosing and managing supraventricular tachycardia, the Global Burden of Disease Study 2010, and more.


September 4th, 2012

You Got the Criminal. But What About the Bystander?

and

A drug-eluting stent is successfully implanted after an acute inferior MI in a fit 70-year-old man. What do you do for the bystander disease detected at the LAD/D1 junction?


August 23rd, 2012

New DES Get COMFORTABLE with AMI

and

The use of drug-eluting stents (DES) in patients with acute myocardial infarction (AMI) has recently generated concern. In two meta-analyses (De Luca et al and Kaleson et al) , the use of early-generation DES resulted in a lower risk of repeat revascularization compared with bare-metal stents (BMS) in patients with AMI, but the DES group had a 2-fold increased […]